Watch the discussion to find out how pharma organizations are increasing their focus on data, analytics and visibility to drive sustainability, flexibility and agility in the supply chain.
The pharma industry is 55 per cent more emission-intensive than the automotive industry, according to the report titled, Carbon footprint of the global pharmaceutical industry and relative impact of its major players. At the same time regulators and society demand safe, affordable and accessible healthcare globally.
For pharma companies to improve their sustainability it is critical that they address the challenges facing their supply chain.
The best way to achieve this is by having a fully digital supply chain which gives visibility on the full value chain, thereby enabling pharma companies to enhance efficiency, adjust routing and suppliers in real time and ensure quality throughout the process.
The current reality however is that for the majority of businesses the supply chain is still highly fragmented with no single digital threat throughout, inhibiting efforts to improve the end to end process.
With this in mind, Dr Barbara Holtz, Expert Business Consultant, Life Sciences at Dassault Systèmes, along with our experts from Bayer Consumer Health and Janssen, explore how to improve sustainability by transitioning from a fragmented to an integrated digital supply chain..
Specifically, this webinar will address:
